PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Bornaprine→

Bornaprine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
20448-86-6
Molecular formula
C21H31NO2
Molecular weight
329.5 g/mol
Drug class
Central antimuscarinic antiparkinsonian agent
Mechanism of action
Blocks central muscarinic acetylcholine receptors, reducing relative cholinergic overactivity in basal ganglia circuits and improving tremor and rigidity in parkinsonism.
Indications / reported uses
  • Treatment of parkinsonian symptoms and selected drug-induced extrapyramidal symptoms in countries where bornaprine remains authorised; current availability is limited and anticholinergic risks apply

Sources: NLM MeSH — Bornaprine · PubMed — Bornaprine antiparkinsonian pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Bornaprine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Bornaprine Permitted Daily Exposure (PDE) report (the Bornaprine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Bornaprine Occupational Exposure Limit (OEL) report (the Bornaprine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.